SCHEMBL6407734

SCHEMBL6407734

O=C(Nc1cccc(Cl)c1O)C(=O)Nc1cc(Cl)cc(Cl)c1O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSPA5 P11021 1/20 0.51
HSP90AA1 P07900 1/20 0.45
GPR35 Q9HC97 1/20 0.42
STK39 Q9UEW8 3/20 0.41
ALDH1A1 P00352 1/20 0.41
CYP3A4 P08684 1/20 0.41
TSHR P16473 1/20 0.41
RECQL P46063 1/20 0.41
HSD17B10 Q99714 1/20 0.41
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
PTGS1 P23219 1/20 0.40
TBXAS1 P24557 1/20 0.40
MAPK1 P28482 1/20 0.40
PTGS2 P35354 1/20 0.40
MAPK14 Q16539 1/20 0.40
AKR1C4 P17516 1/20 0.40
AKR1C3 P42330 1/20 0.40
AKR1C2 P52895 1/20 0.40
AKR1C1 Q04828 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6408837 0.88 HSPA5 (0.47) HSPA5MEN1KMT2AACLYGRIK1
SCHEMBL6410292 0.88 HSPA5 (0.62) HSPA5STK39ALDH1A1CYP3A4TSHR
SCHEMBL6407663 0.86 NPC1 (0.50) HSPA5STK39ALDH1A1MEN1KMT2A
SCHEMBL6411984 0.82 HSPA5 (0.47) HSPA5STK39MEN1KMT2AMAPK1
SCHEMBL6408135 0.81 KCNMA1 (0.55) HSPA5TSHRHSD17B10MEN1KMT2A
SCHEMBL6414621 0.80 HSPA5 (0.48) HSPA5STK39ALDH1A1CYP3A4TSHR
SCHEMBL6407492 0.79 CXCR2 (0.47) HSPA5STK39ALDH1A1MEN1KMT2A
SCHEMBL6407982 0.79 HSPA5 (0.44) HSPA5STK39ALDH1A1CYP3A4MEN1
SCHEMBL6409629 0.78 KDM5A (0.47) HSPA5GPR35STK39ALDH1A1TSHR
SCHEMBL4356208 0.76 TRPV1 (0.60) ALDH1A1MEN1KMT2AMAPK1TRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050124667-A1 Oxamide inhibitors of plasminogen activator inhibitor-1 CEREP SA (FR) 2005-06-09 US claimed
US-20050124667-A1 Oxamide inhibitors of plasminogen activator inhibitor-1 CEREP SA (FR) 2005-06-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050124667-A1 Oxamide inhibitors of plasminogen activator inhibitor-1 SERPINE1, SERPINC1, SERPINB1 HSPA5 4261/4885HSP90AA1 3508/4885GPR35 3140/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.